NCT02633553

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

An Open-label, Multi-center, Randomized Phase III Study of Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 238 (estimated)
• Sponsor: Fudan University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study is designed to investigate whether adjuvant radiotherapy after complete resection has a better survival for stage II or III thymoma.

Detailed description

It is confirmed by many studies that patients of thymoma with complete resection have better prognosis than those with either incomplete resection or without surgery. However,whether patients with stage II or III thymoma could benefit from adjuvant radiotherapy after complete resection remains controversial. The purpose of this study is to investigate whether adjuvant radiotherapy after complete resection can improve survival for stage II or III thymoma.

Conditions

• Thymoma

Interventions

Type	Name	Description
RADIATION	adjuvant radiotherapy	50Gy/25Fx

Timeline

• Start date: 2018-01-10
• Primary completion: 2025-12-01
• Completion: 2029-12-01
• First posted: 2015-12-17
• Last updated: 2023-12-08

Locations

1 site across 1 country: China